Search research articles
Contact Us
Filters
Showing results (571-580 of 595) with videos related to
Page
of 60
Sort By:
Nature Genetics
|
December 11, 2012
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
Rocco Piazza, Simona Valletta, Nils Winkelmann, et al.
Leukemia
|
April 27, 2013
Mutations and prognosis in primary myelofibrosis
A M Vannucchi, T L Lasho, P Guglielmelli, et al.
Leukemia
|
June 8, 2022
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy
Matthew Salmon, Helen E White, Hana Zizkova, et al.
Blood
|
August 20, 2010
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
Helen E White, Paul Matejtschuk, Peter Rigsby, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses
Alexander Amberg, Lisa Beilke, Joel Bercu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 27, 2014
Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples
L Alemany, M Saunier, L Tinoco, et al.
Leukemia
|
December 22, 2018
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
Nicholas C P Cross, Yvette Hoade, William J Tapper, et al.
Leukemia
|
July 11, 2025
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
Jane F Apperley, Dragana Milojkovic, Nicholas C P Cross, et al.
Haematologica
|
November 5, 2010
The European LeukemiaNet: achievements and perspectives
Rüdiger Hehlmann, David Grimwade, Bengt Simonsson, et al.
Blood
|
September 14, 2013
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, et al.
Page
of 60
Search research articles
Search
Showing results (571-580 of 595) with videos related to
Sort By:
Page
of 60
Nature Genetics
|
December 11, 2012
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
Rocco Piazza, Simona Valletta, Nils Winkelmann, et al.
Leukemia
|
April 27, 2013
Mutations and prognosis in primary myelofibrosis
A M Vannucchi, T L Lasho, P Guglielmelli, et al.
Leukemia
|
June 8, 2022
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy
Matthew Salmon, Helen E White, Hana Zizkova, et al.
Blood
|
August 20, 2010
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
Helen E White, Paul Matejtschuk, Peter Rigsby, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses
Alexander Amberg, Lisa Beilke, Joel Bercu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 27, 2014
Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples
L Alemany, M Saunier, L Tinoco, et al.
Leukemia
|
December 22, 2018
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
Nicholas C P Cross, Yvette Hoade, William J Tapper, et al.
Leukemia
|
July 11, 2025
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
Jane F Apperley, Dragana Milojkovic, Nicholas C P Cross, et al.
Haematologica
|
November 5, 2010
The European LeukemiaNet: achievements and perspectives
Rüdiger Hehlmann, David Grimwade, Bengt Simonsson, et al.
Blood
|
September 14, 2013
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, et al.
Page
of 60